CKD Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

CKD wird ein jährliches Gewinn- und Umsatzwachstum von 16.6% bzw. 7.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 16.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 10.9% betragen.

Wichtige Informationen

16.6%

Wachstumsrate der Gewinne

16.8%

EPS-Wachstumsrate

Machinery Gewinnwachstum	9.7%
Wachstumsrate der Einnahmen	7.8%
Zukünftige Eigenkapitalrendite	10.9%
Analystenabdeckung	Good
Zuletzt aktualisiert	18 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

CKD Corporation (TSE:6407) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Nov 17

Recent updates

CKD Corporation (TSE:6407) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Nov 17

CKD Corporation (TSE:6407) Shares Could Be 26% Below Their Intrinsic Value Estimate

Nov 14

CKD Corporation (TSE:6407) Stocks Pounded By 35% But Not Lagging Market On Growth Or Pricing

Aug 05

CKD (TSE:6407) Has Announced That It Will Be Increasing Its Dividend To ¥30.00

Jul 26

A Look At The Fair Value Of CKD Corporation (TSE:6407)

Jul 25

CKD (TSE:6407) Is Increasing Its Dividend To ¥30.00

Jul 11

CKD's (TSE:6407) Returns On Capital Are Heading Higher

Jun 12

Getting In Cheap On CKD Corporation (TSE:6407) Might Be Difficult

May 26

Here's Why CKD (TSE:6407) Has A Meaningful Debt Burden

Apr 12

CKD (TSE:6407) Has Some Way To Go To Become A Multi-Bagger

Mar 12

CKD Corporation's (TSE:6407) Share Price Matching Investor Opinion

Feb 26

Gewinn- und Umsatzwachstumsprognosen

TSE:6407 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (JPY Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
3/31/2027	183,888	19,400	12,969	22,369	8
3/31/2026	169,356	16,589	10,656	20,019	10
3/31/2025	152,307	12,859	8,158	7,404	10
9/30/2024	143,667	10,717	-396	10,721	N/A
6/30/2024	139,480	9,529	N/A	N/A	N/A
3/31/2024	134,425	8,338	-12,991	7,600	N/A
12/31/2023	139,571	9,938	N/A	N/A	N/A
9/30/2023	145,763	11,710	-13,013	8,334	N/A
6/30/2023	154,440	13,526	N/A	N/A	N/A
3/31/2023	159,457	14,788	-702	11,049	N/A
12/31/2022	157,725	14,591	N/A	N/A	N/A
9/30/2022	154,600	13,525	3,751	12,302	N/A
6/30/2022	146,864	12,493	N/A	N/A	N/A
3/31/2022	142,199	12,567	4,115	12,352	N/A
12/31/2021	135,697	11,534	N/A	N/A	N/A
9/30/2021	124,593	9,736	14,141	18,839	N/A
6/30/2021	114,315	7,683	N/A	N/A	N/A
3/31/2021	106,723	5,273	14,563	17,521	N/A
12/31/2020	103,294	4,589	N/A	N/A	N/A
9/30/2020	103,277	4,624	11,609	14,754	N/A
6/30/2020	103,235	4,270	N/A	N/A	N/A
3/31/2020	100,717	3,689	13,169	17,250	N/A
12/31/2019	99,222	3,974	N/A	N/A	N/A
9/30/2019	102,592	3,241	-6,083	5,720	N/A
6/30/2019	108,147	2,853	N/A	N/A	N/A
3/31/2019	115,665	4,793	-18,564	-2,254	N/A
12/31/2018	120,589	5,621	N/A	N/A	N/A
9/30/2018	121,922	7,109	-8,088	3,192	N/A
6/30/2018	121,002	9,304	N/A	N/A	N/A
3/31/2018	115,700	9,142	N/A	5,542	N/A
12/31/2017	111,944	8,933	N/A	N/A	N/A
9/30/2017	105,302	8,425	N/A	7,588	N/A
6/30/2017	98,717	7,859	N/A	N/A	N/A
3/31/2017	94,012	6,958	N/A	10,163	N/A
12/31/2016	91,091	6,115	N/A	N/A	N/A
9/30/2016	85,900	5,336	N/A	7,388	N/A
6/30/2016	85,289	4,962	N/A	N/A	N/A
3/31/2016	88,117	5,459	N/A	8,027	N/A
12/31/2015	85,890	5,818	N/A	N/A	N/A
9/30/2015	88,548	6,711	N/A	8,180	N/A
6/30/2015	88,044	6,530	N/A	N/A	N/A
3/31/2015	83,379	6,010	N/A	6,226	N/A
12/31/2014	81,776	5,384	N/A	N/A	N/A
9/30/2014	79,893	5,163	N/A	7,158	N/A
6/30/2014	77,902	5,337	N/A	N/A	N/A
3/31/2014	75,491	5,456	N/A	9,754	N/A
12/31/2013	72,437	5,122	N/A	N/A	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 6407Das prognostizierte Gewinnwachstum (16.6% pro Jahr) liegt über der Sparquote (0.3%).

Ertrag vs. Markt: 6407Die Erträge des Unternehmens (16.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt JP (7.9% pro Jahr).

Hohe Wachstumserträge: 6407Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: 6407Die Einnahmen des Unternehmens (7.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt JP (4.2% pro Jahr).

Hohe Wachstumseinnahmen: 6407Die Einnahmen des Unternehmens (7.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 6407Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (10.9%).

CKD Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

CKD Corporation (TSE:6407) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Price target increased by 8.0% to JP¥3,646

Price target increased by 7.8% to JP¥3,020

Price target increased by 11% to JP¥2,759

Price target increased by 13% to JP¥2,659

Price target increased by 8.0% to JP¥2,514

Recent updates

CKD Corporation (TSE:6407) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Second quarter 2025 earnings released: EPS: JP¥49.09 (vs JP¥31.32 in 2Q 2024)

CKD Corporation (TSE:6407) Shares Could Be 26% Below Their Intrinsic Value Estimate

Is CKD (TSE:6407) Using Too Much Debt?

Now 20% undervalued after recent price drop

Upcoming dividend of JP¥30.00 per share

CKD (TSE:6407) Is Experiencing Growth In Returns On Capital

CKD (TSE:6407) Will Pay A Larger Dividend Than Last Year At ¥30.00

CKD Corporation to Report Q2, 2025 Results on Nov 12, 2024

Now 20% undervalued after recent price drop

CKD's (TSE:6407) Upcoming Dividend Will Be Larger Than Last Year's

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

CKD Corporation (TSE:6407) Stocks Pounded By 35% But Not Lagging Market On Growth Or Pricing

Investor sentiment deteriorates as stock falls 26%

CKD (TSE:6407) Has Announced That It Will Be Increasing Its Dividend To ¥30.00

A Look At The Fair Value Of CKD Corporation (TSE:6407)

CKD (TSE:6407) Is Increasing Its Dividend To ¥30.00

Final dividend of JP¥30.00 announced

Insufficient new directors

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

CKD's (TSE:6407) Returns On Capital Are Heading Higher

CKD Corporation to Report Q1, 2025 Results on Aug 09, 2024

Getting In Cheap On CKD Corporation (TSE:6407) Might Be Difficult

Price target increased by 8.0% to JP¥3,646

Now 23% overvalued after recent price rise

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

CKD Corporation, Annual General Meeting, Jun 21, 2024

Here's Why CKD (TSE:6407) Has A Meaningful Debt Burden

Upcoming dividend of JP¥22.00 per share

CKD (TSE:6407) Has Some Way To Go To Become A Multi-Bagger

Price target increased by 7.8% to JP¥3,020

Investor sentiment improves as stock rises 18%

CKD Corporation to Report Fiscal Year 2024 Results on May 10, 2024

CKD Corporation's (TSE:6407) Share Price Matching Investor Opinion

Investor sentiment improves as stock rises 19%

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 11% to JP¥2,759

Price target increased by 13% to JP¥2,659

Price target increased by 8.0% to JP¥2,514

CKD Corporation to Report Q3, 2024 Results on Feb 09, 2024

Consensus EPS estimates fall by 14%

Second quarter 2024 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of JP¥26.00 per share at 2.9% yield

CKD Corporation to Report Q2, 2024 Results on Nov 10, 2023

First quarter 2024 earnings: EPS and revenues miss analyst expectations

CKD Corporation to Report Q1, 2024 Results on Aug 10, 2023

Price target increased by 10% to JP¥2,475

Full year 2023 earnings: EPS exceeds analyst expectations

Consensus EPS estimates fall by 10%

CKD Corporation, Annual General Meeting, Jun 23, 2023

Upcoming dividend of JP¥42.00 per share at 3.9% yield

Now 21% undervalued

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

CKD Corporation to Report Q3, 2023 Results on Feb 10, 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of JP¥39.00 per share

CKD Corporation to Report Q2, 2023 Results on Nov 11, 2022

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CKD Corporation to Report Q1, 2023 Results on Aug 10, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

CKD Corporation, Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

CKD Corporation to Report Fiscal Year 2022 Results on May 13, 2022

Price target decreased to JP¥2,582

Upcoming dividend of JP¥22.00 per share

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Second quarter 2022 earnings released: EPS JP¥43.13 (vs JP¥12.40 in 2Q 2021)

Investor sentiment deteriorated over the past week